Product Images Fentanyl

Fentanyl transdermal system is a drug delivery system for the transdermal administration of fentanyl, a potent opioid analgesic. The system delivers 100 mcg/hour of fentanyl for up to 72 hours. It is only intended for use in patients who are already taking other opioid analgesics and are tolerant to their effects. Each system contains 11.04 mg of fentanyl, with isopropyl myristate, octyldodecanol, polybutene, and poyisobutene adhesive as inactive ingredients. The system should be applied immediately after removing it from the blister, and the area should not be exposed to heat. The system should be stored at up to 25°C, and not used if the seal on the blister is broken. Fentanyl is a potent opioid analgesic that can cause respiratory depression if misused. Patients should not use this system for short-term, mild pain or post-operative pain, or pain that can be managed with non-opioid or as-needed opioid medication. The system should be kept out of reach of children.*

The text is a description of the Fentanyl Transdermal System, which provides 12 mey/h of fentanyl for 72 hours. It warns against using it for short-term or occasional pain or mild pain that can be treated with non-opioid medication. It is only for those who have been using other narcotic opioid medicines (must be opioid tolerant). Each system contains 1.38 mg fentanyl and isopropyl myristate, octyldodecanol, polybutene, and polyisobutene adhesive are the inactive ingredients. The dosage information can be found in the product literature. The transdermal system should be applied immediately upon removal from the blister and should not be exposed to heat. It should be stored in the original unopened blister at up to 25°C (77°F), with excursions permitted from 15 to 30°C (59 to 86°F). The text also cautions that the system should not be used if the seal on the blister is broken and should be kept out of the reach of children.*

This text describes three layers, a release liner, a drug-containing layer, and a backing layer. It is unclear what the purpose or composition of these layers are, as there is no additional information provided.*

The Fentanyl Transdermal System delivers 25 mg/h of fentanyl for 72 hours through skin absorption. It should only be used by those who have been tolerant to other narcotic opioid medicines and should not be used for short-term or post-operative pain, mild pain, or pain that can be treated with non-opioid medication. Each transdermal system contains 2.76 mg of fentanyl and a polyisobutene adhesive in addition to other inactive ingredients. Proper storage conditions should be followed, the application process should also be carefully followed while not exposing the application area to heat. It is recommended to read the enclosed medication guide for proper use and safety information.*

Fentanyl Transdermal System is a patch that delivers 37.5 meg/hour of fentanyl for 72 hours for moderate pain. However, it can cause breathing problems that can be fatal, so it should not be used for short term or post-operative pain, occasional pain, or pain that can be treated with non-opioid medicine. It should only be used by people who are opioid tolerant. Each patch contains 414 g of fentanyl and inactive ingredients including isopropyl myristate, octyldodecanol, polybutene, and polycobutene adhesive. The patch should be stored at temperatures between 15-30°C and kept out of reach of children. The enclosed medication guide has important safety information. The product is manufactured by Apotex Corp.*

This is a description about a pain medication called Fentanyl Transdermal System. The system comes in a pack with the NDC code 60505-7082-0, and delivers 50 meg/h of fentanyl for 72 hours through invivo delivery. The text warns that the system is not to be used for short term or post-operative pain, mild pain or pain that can be treated with non-opioid or as-needed opioid medication, unless the user has been using other narcotic opioid medicines. The system should not be exposed to heat and should be stored at temperatures within the range of 15 to 30°C (59 to 86°F). Fentanyl Transdermal System should not be used if the seal on the blister is broken and kept out of reach of children. The text also indicates that there is more information about how to use the system inside the enclosed product literature, and that the user should read the Fentanyl Transdermal System Medication Guide for important safety information.*

This is a description for Fentanyl Transdermal System 62.5 mcg/h. It is a medication for the treatment of mild to severe pain and should not be used for postoperative or short-term pain. Each transdermal system contains 6.90 mg of fentanyl and inactive ingredients such as ecprop myists, ocyHodecano, polbutene, and poisobutns atsie. The dosage information is in the accompanying product brochure. The medication should be kept out of reach of children and stored in a dry and cool place between 15°C to 30°C. The seal should not be broken before use, and the patient should read the enclosed medication guide before use. The manufacturer is Apotex Corp., Weston, FL33325.*

FENTANYL TRANSDERMAL SYSTEM is a drug delivery mechanism that delivers 75 mcg/h of fentanyl over a period of 72 hours. The product contains 8.28 mg of fentanyl and should not be used for mild pain or post-operative pain. The product should be stored between 15°C to 30°C and the blister should not be used if seal is broken. Please refer to the enclosed medication guide for important safety information. The product is manufactured by Apotex Corp., located in Weston, FL.*

The text describes a transdermal system that delivers a certain dose of fentanyl over a 72-hour period. The system shouldn't be used for short-term or post-operative pain or pain that can be treated with non-opioid medications. It is also only recommended for individuals who use other opioid medications. Each system contains 9.66 m fentanyl and should be applied immediately upon removal from the blister, and the area should not be exposed to heat. The medication guide included in the package should be read before use. The system was manufactured by Apotex Corp.*